The AlphaMed Company, Inc.

The AlphaMed Company, Inc. is dedicated to advancing science and medicine to improve lives globally. For over three decades, AlphaMed has driven progress in oncology through trusted publishing, strategic collaboration, and a deep commitment to equitable access to care. By bridging academia and industry, The AlphaMed Company, Inc. fosters partnerships and collaborations, building networks that drive sustainable progress. The AlphaMed Company, Inc.'s commitment to connecting research with clinical practice catalyzed the formation of the Society for Translational Oncology (STO), an independent nonprofit dedicated to bridging scientific discovery and clinical application.

As the founding publisher of The Oncologist, STEM CELLS, and STEM CELLS Translational Medicine, now published by Oxford University Press, The AlphaMed Company, Inc. has long been at the forefront of accelerating the translation of scientific discoveries into practical clinical application. The AlphaMed Company, Inc. is located at its primary address: 318 Blackwell St. Ste 260, Durham, NC 27701, US.

The AlphaMed Company, Inc. continues to expand its reach and impact in the medical and scientific communities. The AlphaMed Company, Inc. is focused on bridging discovery, care, and community impact and is poised for continued growth and innovation in the years to come. We invite the manager of The AlphaMed Company, Inc. to create a customized and exclusive company showcase and product listing on our platform.